Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
21 08 2020
Historique:
received: 10 04 2020
revised: 22 06 2020
pubmed: 10 7 2020
medline: 20 1 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Voltage-gated potassium (Kv) channels of the Kv4 subfamily associate with Kv channel-interacting proteins (KChIPs), which leads to enhanced surface expression and shapes the inactivation gating of these channels. KChIP3 has been reported to also interact with the late endosomal/lysosomal membrane glycoprotein CLN3 (ceroid lipofuscinosis neuronal 3), which is modified because of gene mutation in juvenile neuronal ceroid lipofuscinosis (JNCL). The present study was undertaken to find out whether and how CLN3, by its interaction with KChIP3, may indirectly modulate Kv4.2 channel expression and function. To this end, we expressed KChIP3 and CLN3, either individually or simultaneously, together with Kv4.2 in HEK 293 cells. We performed co-immunoprecipitation experiments and found a lower amount of KChIP3 bound to Kv4.2 in the presence of CLN3. In whole-cell patch-clamp experiments, we examined the effects of CLN3 co-expression on the KChIP3-mediated modulation of Kv4.2 channels. Simultaneous co-expression of CLN3 and KChIP3 with Kv4.2 resulted in a suppression of the typical KChIP3-mediated modulation;

Identifiants

pubmed: 32641494
pii: S0021-9258(17)50071-X
doi: 10.1074/jbc.RA120.013828
pmc: PMC7443505
pii:
doi:

Substances chimiques

CLN3 protein, human 0
KCNIP3 protein, human 0
Kv Channel-Interacting Proteins 0
Membrane Glycoproteins 0
Molecular Chaperones 0
Repressor Proteins 0
Shal Potassium Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12099-12110

Informations de copyright

© 2020 Seifert et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Hum Mol Genet. 2008 Nov 1;17(21):3332-9
pubmed: 18678598
J Physiol. 2001 Aug 15;535(Pt 1):65-81
pubmed: 11507158
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10144-9
pubmed: 12114547
Biochem Biophys Res Commun. 2003 May 23;305(1):62-6
pubmed: 12732196
Pflugers Arch. 2017 Nov;469(11):1457-1470
pubmed: 28735419
J Neurosci. 2016 Nov 2;36(44):11196-11207
pubmed: 27807163
J Neurophysiol. 1994 Oct;72(4):1516-29
pubmed: 7823083
Neurology. 2012 Jul 10;79(2):183-91
pubmed: 22778232
Neurobiol Dis. 2006 Jun;22(3):575-85
pubmed: 16483786
J Neurosci. 2006 Nov 22;26(47):12137-42
pubmed: 17122038
Dis Model Mech. 2015 Apr;8(4):351-61
pubmed: 26035843
Brain Res Bull. 2012 May 1;88(1):43-57
pubmed: 22502604
Nat Med. 1998 Oct;4(10):1177-81
pubmed: 9771752
J Neurosci. 2010 Oct 13;30(41):13644-55
pubmed: 20943905
Am J Hum Genet. 1997 Aug;61(2):310-6
pubmed: 9311735
Am J Med Genet. 1995 Jun 5;57(2):137-41
pubmed: 7668317
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):403-9
pubmed: 17197420
J Biol Chem. 2006 Jul 21;281(29):20483-93
pubmed: 16714284
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8590-3
pubmed: 10900016
Neurosci Lett. 1997 Aug 29;232(2):91-4
pubmed: 9302094
Hum Mol Genet. 1999 Jun;8(6):1091-8
pubmed: 10332042
Neurosci Lett. 2005 Apr 11;378(1):59-64
pubmed: 15763173
Mol Cell Neurosci. 2002 Apr;19(4):552-9
pubmed: 11988022
J Biol Chem. 2003 Sep 19;278(38):36445-54
pubmed: 12829703
Exp Cell Res. 2008 Sep 10;314(15):2895-905
pubmed: 18621045
eNeuro. 2018 May 17;5(2):
pubmed: 29780879
Neuropediatrics. 1990 May;21(2):95-101
pubmed: 2359490
J Physiol. 2002 Feb 1;538(Pt 3):691-706
pubmed: 11826158
Neurochem Int. 2011 May;58(6):648-55
pubmed: 21315126
J Neurosci Res. 2005 Mar 1;79(5):573-83
pubmed: 15657902
Hum Mol Genet. 2007 Feb 1;16(3):317-26
pubmed: 17189291
Science. 2004 Jul 23;305(5683):532-5
pubmed: 15273397
Elife. 2017 Nov 14;6:
pubmed: 29135436
Nature. 1997 Jun 26;387(6636):869-75
pubmed: 9202119
Neuron. 2003 Feb 6;37(3):449-61
pubmed: 12575952
Neuroscience. 2008 Oct 15;156(3):550-62
pubmed: 18727953
Nature. 1999 Mar 4;398(6722):80-4
pubmed: 10078534
Cell. 1995 Sep 22;82(6):949-57
pubmed: 7553855
Genomics. 2005 Nov;86(5):581-93
pubmed: 16112838
J Biol Chem. 2005 May 13;280(19):18853-61
pubmed: 15671030
J Biol Chem. 2001 Jun 29;276(26):23888-94
pubmed: 11287421
PLoS One. 2018 Jan 31;13(1):e0191911
pubmed: 29385176
Mol Genet Genomic Med. 2019 Dec;7(12):e859
pubmed: 31568712
Hum Mol Genet. 2000 Mar 22;9(5):735-44
pubmed: 10749980
Channels (Austin). 2018;12(1):187-200
pubmed: 30070159
Neuron. 1992 Jun;8(6):1055-67
pubmed: 1610565
J Neurosci. 2013 May 1;33(18):7811-24
pubmed: 23637173
Nat Neurosci. 2010 Mar;13(3):333-7
pubmed: 20154682
J Neurochem. 2008 Aug;106(4):1929-40
pubmed: 18513371
J Biol Chem. 2015 Jun 5;290(23):14361-80
pubmed: 25878248
Hum Mol Genet. 2008 Jan 15;17(2):303-12
pubmed: 17947292
Neuroradiology. 1996 Jul;38(5):476-82
pubmed: 8837098
J Neurosci. 2014 Jun 25;34(26):8800-12
pubmed: 24966380
Sci Rep. 2019 May 13;9(1):7260
pubmed: 31086218
J Biol Chem. 2019 Mar 8;294(10):3683-3695
pubmed: 30622142
Nature. 2000 Feb 3;403(6769):553-6
pubmed: 10676964
Neuroscience. 2008 Dec 2;157(3):566-76
pubmed: 18930118
Biophys J. 2004 Oct;87(4):2380-96
pubmed: 15454437
J Neurosci. 2005 Nov 23;25(47):10863-73
pubmed: 16306399
J Neurosci. 2001 Sep 1;21(17):6626-34
pubmed: 11517252
Cell Mol Life Sci. 2011 Feb;68(3):453-74
pubmed: 20680390
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2287-91
pubmed: 26093153

Auteurs

Carolin Seifert (C)

Institut für Zelluläre und Integrative Physiologie, Zentrum für Experimentelle Medizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Stephan Storch (S)

Klinik und Poliklinik für Kinder- und Jugendmedizin, Pädiatrische Forschung, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Robert Bähring (R)

Institut für Zelluläre und Integrative Physiologie, Zentrum für Experimentelle Medizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. Electronic address: r.baehring@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH